about
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesAntioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescentsSignal transductions and nonalcoholic fatty liver: a mini-reviewChronic liver injury induced by drugs: a systematic review.TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in MiceGaps in recognition and evaluation of incidentally identified hepatic steatosisNon-alcohol fatty liver disease in Asia: Prevention and planning.The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).Inhibitors of Fatty Acid Synthesis Induce PPAR α -Regulated Fatty Acid β -Oxidative Genes: Synergistic Roles of L-FABP and GlucoseInsulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the BrainSubclassification of fatty liver by its pathogenesis: cIEFing is believingNutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients.Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in miceFimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy.Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD).Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid LevelsZebrafish lipid droplets regulate embryonic ATP homeostasis to power early development.Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study.Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes.The Use of Computed Tomography in the Diagnosis of Fatty Liver and Abdominal Fat Distribution among a Saudi Population.Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma.High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progressionUltrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic SyndromeIncreased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver
P2860
Q26741550-E960A80A-B3DA-40BB-A794-77F4E0DE2003Q26825364-DB83574A-4BD8-48B1-BCEF-8D893C42B2F2Q26991757-8AFFFA2A-E0D6-47EC-84DE-50ED1991E55CQ30278737-9522987C-B250-453C-BF32-0851C254EC5FQ33600346-1318ADA7-7500-4B65-9CCA-B6121430080BQ35272016-2DBD47EE-82AF-4961-A2AD-700214A549D6Q35819344-6A76615C-127A-44CB-B190-E2A185242F33Q36123336-22E09C4C-C3F5-4211-92F8-7AA71926B12FQ36692326-0C01DB1F-494B-443A-90EE-6F7F5DB42B46Q36930787-8E55E4C2-1E00-448E-960F-BADB654FEEEFQ36961045-7D2406FD-09D0-415D-B495-E242363B5E9DQ37286751-ED30C6B6-4B4F-4743-8F39-E03309991573Q37409370-0864D942-C6E3-49ED-A0A4-0A7E99EBAEA9Q37624843-FEBA1EB2-64EB-4EAE-9FFF-4CF9078E8010Q37721436-1F8ADF30-8185-42BB-82D5-CCB3894E9FCEQ37733119-24E56A16-125C-4FEB-88B5-5BD576F539D9Q38657207-F465EB6F-5899-4F42-8032-778544D11A9DQ39371640-11A8DD37-87AF-419E-94A1-E8E76A5F6E90Q39567437-BF2D1A70-DB2C-4A07-BF25-E11C4B6AA793Q41225348-E9292F58-F0E7-483B-A134-992AAE20EE1EQ41449920-65D6865D-BCE7-4C34-9A86-21A2EE8AA5D1Q41605338-328FC602-F8F8-4406-8B0F-2703DB4232D5Q41706829-342248B7-27EF-42B7-A18A-A2FDEB59728FQ41787664-63C9BA5F-61CE-4350-BBC6-37C3F94AD824Q45383113-9FE9C74D-AF6D-4CDA-B2FA-7F4F97D30E02Q48214095-0A42BA1C-5A6D-40B3-A1B5-CE8DFB6D69FBQ53695024-0F75DB11-6DB4-41BB-A159-0715E408BD64Q53752953-1F4A349F-30F3-4D9C-BAA4-D4A2ED19CD2AQ55278796-33B27280-3BBA-4E4F-AD51-0F9A1869F70AQ57116884-91658A16-F86E-48E3-B02C-C7CFE69D5C29Q58711515-D77099E2-BE73-48A5-9B5A-4494D49AFB32Q58799660-AC1ECB4E-0B4F-4363-B7E1-F603BD504DB6
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Secondary causes of nonalcoholic fatty liver disease.
@ast
Secondary causes of nonalcoholic fatty liver disease.
@en
type
label
Secondary causes of nonalcoholic fatty liver disease.
@ast
Secondary causes of nonalcoholic fatty liver disease.
@en
prefLabel
Secondary causes of nonalcoholic fatty liver disease.
@ast
Secondary causes of nonalcoholic fatty liver disease.
@en
P2093
P2860
P356
P1476
Secondary causes of nonalcoholic fatty liver disease.
@en
P2093
Jacob M Kneeman
Joseph Misdraji
Kathleen E Corey
P2860
P304
P356
10.1177/1756283X11430859
P577
2012-05-01T00:00:00Z